Cited by 664Adipokines, Inflammation, and Metabolic DiseasesLipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study

Rutter, Martin K., Meigs, James B., Sullivan, Lisa M., D’Agostino, Ralph B., Wilson, Peter W.F.·2004·Circulation

DOI 10.1161/01.cir.0000136581.59584.0e

Open this paper in CoChat — free account

Abstract

Background— Inflammation (assessed by C-reactive protein [CRP]) and the metabolic syndrome (MetS) are associated with cardiovascular disease (CVD), but population-based data are limited. Methods and Results— We assessed the cross-sectional relations of CRP to the MetS (National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Adult Treatment Panel III definition) in 3037 subjects (1681 women; mean age, 54 years) and the utility of CRP and the MetS to predict new CVD events (n=189) over 7 years. MetS (≥3 of 5 traits) was present in 24% of subjects; mean age-adjusted CRP levels for those with 0, 1, 2, 3, 4, or 5 MetS traits were 2.2, 3.5, 4.2, 6.0, or 6.6 mg/L, respectively ( P trend <0.0001). In persons with MetS, age-adjusted CRP levels were higher in women than men (7.8 versus 4.6 mg/L; P <0.0001). MetS and baseline CRP were individually related to CVD events (for MetS: age-sex-adjusted hazard ratio [HR], 2.1; 95% CI, 1.5 to 2.8; for highest versus lowest CRP quartile: HR, 2.2; 95% CI, 1.4 to 3.5). Greater risk of CVD persisted for MetS and CRP even after adjustment in a model including age, sex, MetS (HR, 1.8; 95% CI, 1.4 to 2.5), and CRP (HR, 1.9; 95% CI, 1.2 to 2.9). The c-statistic associated with the age- and sex-adjusted model including CRP was 0.72; including MetS, 0.74; and including CRP and MetS, 0.74. Conclusions— Elevated CRP levels are related to insulin resistance and the presence of the MetS, especially in women. Although discrimination of subjects at risk of CVD events using both MetS and CRP is not better than using either phenotype alone, both CRP and MetS are independent predictors of new CVD events.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000136581.59584.0e

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction: A Potential Role for Cytokines Originating From Adipose Tissue?
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,366
Self-citation
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women
Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080897.52664.94 · Cited by 1,506
Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study
Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I. R., Tracy, R. P., & HEISS, G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,080
Elevated Levels of Acute-Phase Proteins and Plasminogen Activator Inhibitor-1 Predict the Development of Type 2 Diabetes
Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
Self-citation
Is Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,042

Show all 36 references

Research works printed but not linked: 7

10.1161/atvb.19.4.972 · DOI
10.1161/circ.102.1.42 · DOI
10.1161/str.32.11.2575 · DOI
1998, Diabetologia, 4, 1241
2003, Clin Chem Lab Med, 41, 1120
10.1210/jcem.86.9.7873 · DOI · Paper page
10.1001/jama.1991.03460050081025 · DOI

Sorted by citations

Items 301–400 of 662

Interplay Between Systemic Inflammation and Markers of Insulin Resistance in Cardiovascular Prognosis After Heart Transplantation
Biadi, O., Potena, L., Fearon, W. F., Luikart, H. I., Yeung, A. C., Ferrara, R., Hunt, S. A., Mocarski, E. S., & Valantine, H. A. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.01.020 · Cited by 29
C-reactive protein and cardiovascular disease: a critical appraisal
Sepulveda, J. L., & Mehta, J. L. (2005) · Current Opinion in Internal Medicine · doi:10.1097/01.hco.0000175518.57804.94 · Cited by 27
Polycystic Ovary Syndrome
Sattar, N. A., & Fleming, R. (2005) · doi:10.1002/0470025131.ch12 · Cited by 29
The association between the metabolic syndrome and peripheral, but not coronary, artery disease is partly mediated by endothelial dysfunction: the CODAM study
Jacobs, M., van Greevenbroek, M. M. J., Kallen, C., Ferreira, I., Blaak, E. E., Feskens, E. J. M., Jansen, E. H. J. M., Schalkwijk, C. G., & Stehouwer, C. D. A. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02392.x · Cited by 28
A Perspective on the New American College of Cardiology/American Heart Association Guidelines for Cardiovascular Risk Assessment
Kullo, I. J., Trejo-Gutiérrez, J. F., López-Jiménez, F. A., Thomas, R. J., Allison, T. G., Mulvagh, S. L., Arruda-Olson, A. M., Hayes, S. N., Pollak, A. W., Kopecky, S. L., et al. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.06.018 · Cited by 28
Metabolic Syndrome and Prediabetes
Babu, A. R., & Fogelfeld, L. A. (2006) · Disease-a-Month · doi:10.1016/j.disamonth.2006.03.001 · Cited by 27
C reactive protein and its determinants in healthy men and women from European regions at different risk of coronary disease: the IMMIDIET Project
Arcari, A., Zito, F., Castelnuovo, A. F. D., Curtis, A. D., Dirckx, C., Arnout, J., Cappuccio, F. P., DONGEN, M. C. J. M. V., de Lorgeril, M., Krogh, V., et al. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02851.x · Cited by 28
P‐Wave Duration and Dispersion in Patients with Metabolic Syndrome
Yaşar, A. S., Bilen, E., BİLGE, M., İpek, G., İpek, E., & Kırbaş, Ö. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02460.x · Cited by 29
Impaired sleep quality is associated with concurrent elevations in inflammatory markers: are post-menopausal women at greater risk?
D’Antono, B., & Bouchard, V. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0250-x · Cited by 28
Syringic Acid Ameliorates Cardiac, Hepatic, Renal and Neuronal Damage Induced by Chronic Hyperglycaemia in Wistar Rats: A Behavioural, Biochemical and Histological Analysis
Mirza, A. C., Panchal, S. S., Allam, A. A., Othman, S. I., Satia, M., & Mandhane, S. N. (2022) · Molecules · doi:10.3390/molecules27196722 · Cited by 32
“In our study, there was an elevated serum CRP level in nSTZ diabetic rats, which is consistent with earlier studies demonstrating increased serum CRP levels in diabetic individuals and rats with STZ-induced T2DM [133,134].”
Result
Abdominal obesity and other risk factors largely explain the high CRP in Indigenous Australians relative to the general population, but not gender differences: a cross-sectional study
Hodge, A. M., Maple-Brown, L. J., Cunningham, J., Boyle, J. A., Dunbar, T., Weeramanthri, T. S., Shaw, J. E., & O’Dea, K. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-700 · Cited by 27
“Other studies have variously shown that women had CRP concentrations higher than men [8-11] (including a study of Indigenous Australians [4]), similar to men [5] or lower than men [12].”
BackgroundResultInfluential
Metabolic syndrome defined by IDF and AHA/NHLBI correlates better to carotid intima-media thickness than that defined by NCEP ATP III and WHO
Ma, W.-Y., Li, H., Hung, C. S., Lin, M., Chiu, F., Lin, C.-H., Shih, S., Chuang, L., & Wei, J. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.06.020 · Cited by 27
Long‐term efficacy and safety of ezetimibe/simvastatin coadministered with extended‐release niacin in hyperlipidaemic patients with diabetes or metabolic syndrome
Fazio, S., Guyton, J. R., Lin, J., Tomassini, J. E., Shah, A. K., & Tershakovec, A. M. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01289.x · Cited by 26
Bath Breakfast Project (BBP) - Examining the role of extended daily fasting in human energy balance and associated health outcomes: Study protocol for a randomised controlled trial [ISRCTN31521726]
Betts, J. A., Thompson, D., Richardson, J. D., Chowdhury, E. A., Jeans, M., Holman, G. D., & Tsintzas, K. (2011) · Trials · doi:10.1186/1745-6215-12-172 · Cited by 27
“In particular, systemic concentrations of C-reactive protein (CRP) have been shown to exhibit positive correlations with fasted glucose concentrations [60], atherosclerotic progression [61] and the incidence of initial coronary heart disease events [62].”
Background
Leptin and high-sensitivity C-reactive protein and their interaction in the metabolic syndrome in middle-aged subjects
Ukkola, O. H., & Kesäniemi, Y. A. (2007) · Metabolism · doi:10.1016/j.metabol.2007.04.019 · Cited by 28
Resting heart rate, heart rate reserve, and metabolic syndrome in professional firefighters: A cross‐sectional study
Choi, B., Ko, S., & Kojaku, S. (2017) · American Journal of Industrial Medicine · doi:10.1002/ajim.22752 · Cited by 26
Prediction of Type 2 Diabetes by Hemoglobin A1c in Two Community-Based Cohorts
Leong, A., Daya, N. R., Porneala, B., Devlin, J. J., Shiffman, D., McPhaul, M. J., Selvin, E., & Meigs, J. B. (2017) · Diabetes Care · doi:10.2337/dc17-0607 · Cited by 28
“HDL and triglycerides (TG)were determined using a commercially available assay (Hemagen Diagnostics, Inc, Waltham, MA) in FHS (21,22) and the Roche Cobas Bio analyzer”
MethodSelf-citation
Short-term exposure to ambient ozone and cardiovascular mortality in China: a systematic review and meta-analysis
Guo, X., Su, W., Wang, H., Li, N., Song, Q., Liang, Q., Sun, C., Liang, M., Zhou, Z., Song, E. J., et al. (2022) · International Journal of Environmental Health Research · doi:10.1080/09603123.2022.2066070 · Cited by 28
“2015), which is a possible risk factor for cardiovascular disease (Rutter et al. 2004).”
Background
Tumor Necrosis Factor and Alzheimer's Disease: A Cause and Consequence Relationship
Sharma, V., Thakur, V. B. S., Singh, S. N., & Guleria, R. (2012) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20120112064639 · Cited by 26
“Proc Natl Acad Sci USA 1975;72(9):3666-70.”
Influential
Waist circumference as the predominant contributor to the micro-inflammatory response in the metabolic syndrome: a cross sectional study
Rogowski, O., Shapira, I., Bassat, O. K., Chundadze, T., Finn, T., Berliner, S. A., & Steinvil, A. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-35 · Cited by 26
“Background The metabolic syndrome (MetS) is associated with the presence of a low grade sub-clinical inflammatory process, so called micro-inflammation [1-7].”
Background
Increased Serum Angiopoietin-Like 6 Ahead of Metabolic Syndrome in a Prospective Cohort Study
Namkung, J., Sohn, J. H., Chang, J. S., Park, S., Kim, J., Koh, S. B., Kong, I. D., & Park, K. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0080 · Cited by 26
Intensified Screening and Treatment of the Metabolic Syndrome for Cardiovascular Risk Reduction
Wong, N. D. (2005) · Preventive Cardiology · doi:10.1111/j.1520-037x.2005.4073.x · Cited by 26
C‐Reactive Protein in Cardiovascular Risk Assessment: A Review of the Evidence
Abraham, J., Campbell, C. Y., Cheema, A., Gluckman, T. J., Blumenthal, R. S., & Danyi, P. (2007) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2007.05950.x · Cited by 26
Intervenção nutricional e o impacto na adesão ao tratamento em pacientes com síndrome Metabólica
Busnello, F. M., Bodanese, L. C., Pellanda, L. C., & Santos, Z. E. D. A. (2011) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2011005000077 · Cited by 25
Serum C-Reactive Protein and Risk of Cardiovascular Events in Middle-Aged and Older Chinese Population
Jiang, S., Bao, Y., Hou, X., Fang, Q., Wang, C., Pan, J., Zuo, Y., Zhong, W., Xiang, K., & Jia, W. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.02.028 · Cited by 25
Metabolic syndrome does not impact long‐term survival in patients with acute myocardial infarction after successful percutaneous coronary intervention with drug‐eluting stents
Won, K., Kim, B., Chang, H., Shin, D., Kim, J., Ko, Y., Choi, D., Ha, J., Hong, M., & Jang, Y. (2013) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.25150 · Cited by 25
“MS is strongly associated with systemic inflammation characterized by high levels of CRP in the general population [30,31].”
Background
Inflammatory Markers in Relation to Nonalcoholic Fatty Liver Disease in Urban South Indians
Gokulakrishnan, K., Anjana, R. M., Deepa, M., Paramasivam, P., Chandrakumar, S., Velmurugan, K., & Mohan, V. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0213 · Cited by 25
“In individuals with high hsCRP and leukocyte count, there is a high risk of cardiovascular disease, 3,28 but it is unknown whether this risk extends to subjects with NAFLD.”
Metabolic Syndrome and Risk of Coronary, Cerebral, and Peripheral Vascular Disease in a Large Dutch Population With Familial Hypercholesterolemia
Rana, J. S., Jansen, A. C. M., Zwinderman, A. H., Nieuwdorp, M., van Aalst-Cohen, E. S., Jukema, J. W., Trip, M. D., & Kastelein, J. J. P. (2006) · Diabetes Care · doi:10.2337/dc05-2530 · Cited by 25
MetS and cardiovascular risk factors among Palestinians of East Jerusalem.
Sham'a, R. A. H. A., Darwazah, A. K., Kufri, F. H., Yassin, I. H., & Torok, N. I. (2009) · PubMed · Cited by 24
Determinants of the aortic pulse wave velocity index in hypertensive and diabetic patients
Vallée, A., Yannoutsos, A., Temmar, M., Dreyfuss-Tubiana, C., Spinu, I., Zhang, Y., Protogerou, A. D., Henry-Bonniot, G., Sosner, P., Safar, M. E., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001828 · Cited by 24
Sex beyond cardiovascular risk factors and clinical biomarkers of cardiovascular disease
Bergami, M., Scarpone, M., Bugiardini, R., Cenko, E., & Manfrini, O. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2301019 · Cited by 29
Gender Differences in the Prevalence and Determinants of the Metabolic Syndrome in Screened Subjects at Risk for Coronary Heart Disease
Tonstad, S., Sandvik, E., Larsen, P. G. L., & Thelle, D. S. (2007) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2006.0037 · Cited by 24
“20 Several of these findings were confirmed in the current study.”
Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL study
Villaseñor, A., Ambs, A. H., Ballard-Barbash, R. R., Baumgartner, K. B., McTiernan, A., Ulrich, C. M., & Neuhouser, M. L. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1474-6 · Cited by 24
“Epidemiological evidence supports a role for inflammation in the etiology of several chronic diseases; the most notable being cardiovascular disease (CVD), diabetes, and several types of cancer [1–4].”
Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)
Robinson, J. G., Ballantyne, C. M., Hsueh, W. A., Rosen, J., Lin, J., Shah, A. K., Lowe, R. S., Hanson, M. E., & Tershakovec, A. M. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.06.004 · Cited by 23
Insulin resistance is significantly associated with the metabolic syndrome, but not with sonographically proven peripheral arterial disease
Vonbank, A., Saely, C. H., Rein, P., & Drexel, H. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-106 · Cited by 24
Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population
Kang, Y. M., Jung, C. H., Cho, Y. K., Lee, S. E., Lee, M. J., Hwang, J. Y., Kim, E. H., Park, J., Lee, W. J., & Kim, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175762 · Cited by 23
Association between fasting plasma glucose and high-sensitivity C-reactive protein: gender differences in a Japanese community-dwelling population
Kawamoto, R., Tabara, Y., Kohara, K., Miki, T., Kusunoki, T., Takayama, S., Abe, M., Katoh, T., & Ohtsuka, N. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-51 · Cited by 23
“Several studies support the concept that high-sensitivity C-reactive protein (hsCRP), even when within the clinical normal range, is an important precursor of the metabolic syndrome (MetS) and type 2 diabetes [1-3], and it may be an independent predictor that reflects early stage cardiovascular disease (CVD) [4-6].”
Influential
Sex Differences in High Sensitivity C-Reactive Protein in Subjects with Risk Factors of Metabolic Syndrome
Garcia, V. P., Rocha, H. N. M., Sales, A. R. K., Rocha, N. G., & da Nóbrega, A. C. L. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160027 · Cited by 23
The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease
Lee, W.-L., Lee, W., Chen, Y., Liu, T.-J., Liang, K., Ting, C.-T., & Sheu, W. H. (2006) · Metabolism · doi:10.1016/j.metabol.2006.03.013 · Cited by 23
“Subjects with metabolic syndrome present a prothrombotic and pro-inflammatory state [19,20].”
Background
Association between inflammatory biomarkers and adiposity in obese patients with heart failure and metabolic syndrome
Motie, M., Evangelista, L. S., Horwich, T. B., Lombardo, D. M., Zaldivar, F. P., Hamilton, M. A., & Fonarow, G. C. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1673 · Cited by 23
“Whilst studies investigating the association between CRP and adiposity are widespread in various populations (8-11, 29 ), the association The mechanisms linking CRP with leptin in different disease models is not well understood.”
Aortic and Pulmonary Artery Stiffness and Cardiac Function in Children at Risk for Obesity
Mahfouz, R. A., Dewedar, A., Abdelmoneim, A., & Hossien, E. M. (2012) · Echocardiography · doi:10.1111/j.1540-8175.2012.01736.x · Cited by 22
Genes, Fat Intake, and Cardiovascular Disease Risk Factors in the Quebec Family Study
Robitaille, J., Përusse, L., Bouchard, C., & Vohl, M. (2007) · Obesity · doi:10.1038/oby.2007.277 · Cited by 22
“Abdominal obesity, hypertriglyceridemia, hypoalphalipoproteinemia, hypertension, and insulin resistance are all independent risk factors for CVD (3), but they also tend to cluster together, conferring additive risk for the development of CVD (4).”
Background
Association of C-reactive protein and metabolic syndrome in a rural Chinese population
Wen, J., Liang, Y., Wang, F., Sun, L.-P., Guo, Y., Duan, X., Liu, X., Tao, Q., Wong, T. Y., Lü, X., et al. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.03.026 · Cited by 22
Comparison of adipokine concentrations and markers of inflammation in obese versus lean dogs.
Eirmann, L., Freeman, L., Laflamme, D. P., Michel, K. E., & Satyaraj, E. (2009) · The journal of applied research in veterinary medicine · Cited by 22
Diabetes and the metabolic syndrome—When is it best to intervene to prevent?
Haffner, S. M. (2006) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2006.01.002 · Cited by 22
Association of Uremic Toxins and Inflammatory Markers with Physical Performance in Dialysis Patients
Pajek, M., Jerman, A., Osredkar, J., Buturović‐Ponikvar, J., & Pajek, J. (2018) · Toxins · doi:10.3390/toxins10100403 · Cited by 21
“Chronic low-level inflammation is associated with poor cardiovascular outcomes [18,19] and cardiovascular morbidity [20,21].”
Background
Coronary Artery Disease Is Associated with an Increased Amount of T Lymphocytes in Human Epicardial Adipose Tissue
Mráz, M., Cinkajzlová, A., Kloučková, J., Lacinová, Z., Kratochvílová, H., Lipš, M., Pořízka, M., Kopecký, P., Pierzynová, A., Kučera, T., et al. (2019) · Mediators of Inflammation · doi:10.1155/2019/4075086 · Cited by 21
Metabolic Syndrome versus Framingham Risk Score for Association of Self-Reported Coronary Heart Disease: The 2005 Korean Health and Nutrition Examination Survey
Kang, H. M., & Kim, D. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.3.237 · Cited by 21
“Many studies have shown that whether defined on the basis of National Cholesterol Education Program (NCEP) criteria [9-21] or World Health Organization (WHO) criteria [2,10,11, 18,22], MetS is associated with significantly increased risk of developing CHD.”
Background
Baseline forced expiratory volume in the first second as an independent predictor of development of the metabolic syndrome
Hsiao, F., Wu, C., Su, S., Sun, M.-T., Hsieh, C., Hung, Y.-J., He, C., & Pei, D. (2009) · Metabolism · doi:10.1016/j.metabol.2009.10.001 · Cited by 21
“In addition, Rutter et al [33] found that systemic inflammation correlates positively with the MetS.”
Background
Association of Inflammatory and Oxidative Stress Markers with Metabolic Syndrome in Asian Indians in India
Rao, V., Nagaraj, R. K., Hebbagodi, S., Kadarinarasimhiah, N. B., & Kakkar, V. V. (2010) · Cardiology Research and Practice · doi:10.4061/2011/295976 · Cited by 21
“Higher levels of circulating cytokines stimulate the hepatic production of C-reactive protein (CRP) [10] and reduced production of the anti-inflammatory and insulin sensitizing cytokine, adiponectin has been associated with MetS [11].”
Background
White Blood Cell Count to Mean Platelet Volume Ratio Is a Prognostic Factor in Patients with Non-ST Elevation Acute Coronary Syndrome with or without Metabolic Syndrome
Dehghani, M. R., Rezaei, Y., Fakour, S., & Arjmand, N. (2016) · Korean Circulation Journal · doi:10.4070/kcj.2016.46.2.229 · Cited by 22
Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation
Polovina, M. M., Hindricks, G., Maggioni, A. P., Piepoli, M. F., Vardas, P. E., Ašanin, M., Đikić, D., Đuričić, N., Milinković, I., & Seferovic, P. M. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy446 · Cited by 21
Sex differences in the association of metabolic syndrome with low back pain among middle-aged Japanese adults: a large-scale cross-sectional study
Yoshimoto, T., Ochiai, H., Shirasawa, T., Nagahama, S., Uehara, A., Sai, S., & Kokaze, A. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0249-3 · Cited by 21
C-Reactive Protein and Incident Left Ventricular Hypertrophy in Essential Hypertension
Assadi, F. K. (2007) · Pediatric Cardiology · doi:10.1007/s00246-006-0173-2 · Cited by 21
“Recent epidemiologic studies document the association between CRP and a variety of other cardiovascular risk factors, such as the presence of metabolic syndrome including type II diabetes, obesity, hyperlipidemia, and hyperglycemia [21].”
BackgroundResultInfluential
Risk Functions and the Primary Prevention of Cardiovascular Disease
Grau, M., & Marrugat, J. (2008) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(08)60141-3 · Cited by 21
The obesity epidemic in the United States: role of cardiac rehabilitation
Savage, P. D., & Ades, P. A. (2006) · Coronary Artery Disease · doi:10.1097/00019501-200605000-00004 · Cited by 21
Persistent elevation of paraoxonase-1 specific enzyme activity after weight reduction in obese non-diabetic men with metabolic syndrome
Liang, K., Lee, W., Lee, I., Lee, W.-L., Lin, S., Hsu, S., Wan, C., Yu, C.-Y., Tsai, I., Fu, C., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.06.018 · Cited by 21
C-reactive protein in risk prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study
Tohidi, M., Hadaegh, F., Harati, H., & Azizi, F. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.11.085 · Cited by 21
“In our study, same as most other studies, addition of CRP did not improve the AUC of Framingham risk function [15,23,25].”
Result
Predictive value of ceruloplasmin for metabolic syndrome in adolescents
González‐Jiménez, E., Schmidt‐RioValle, J., Sinausia, L., Valenza, M. C., & Perona, J. S. (2016) · BioFactors · doi:10.1002/biof.1258 · Cited by 21
The Promising Frontier of Cardiometabolic Syndrome: A New Paradigm in Cardiology
Khan, A. R., Salama, A. H., Aleem, Z., Alfakeer, H., Alnemr, L., & Shareef, A. M. M. (2023) · Cureus · doi:10.7759/cureus.45542 · Cited by 20
Diabetes exacerbates angiographic coronary lesion progression in subjects with metabolic syndrome independent of CRP levels
Liang, K., Lee, W., Lee, W.-L., Chen, Y., Ting, C.-T., & Sheu, W. H. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.10.003 · Cited by 20
Estimation of the Long-term Cardiovascular Events Using UKPDS Risk Engine in Metabolic Syndrome Patients.
Shivakumar, V., Kandhare, A. D., Rajmane, A. R., Adil, M., Ghosh, P., Lb, B., Saraf, M. N., & Bodhankar, S. L. (2014) · Europe PMC (PubMed Central) · Cited by 20
Risk for Cardiovascular Disease and One-Year Mortality in Patients With Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Syndrome Overlap Syndrome
Tang, M., Wang, Y., Wang, M., Tong, R. M., & Shi, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.767982 · Cited by 20
Screening for subclinical atherosclerosis by noninvasive methods in asymptomatic patients with risk factors
Castellon, X., & Богданова (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s40150 · Cited by 22
“Traditional risk factors predict future cardiovascular events and are major determinants in the assessment of cardiovascular risk (Framingham score 74,75 and EuroSCORE 76–79 ) and the choice of primary prevention strategy.”
Cardiometabolic biomarkers in chronic plaque psoriasis before and after etanercept treatment
Puig, L., Strohal, R., Fuiman, J., Pedersen, R. D., Szumski, A. E., Koenig, A. S., Robertson, D., & Drexel, H. (2013) · Journal of Dermatological Treatment · doi:10.3109/09546634.2013.848260 · Cited by 20
“CRP levels have been shown to correlate strongly with metabolic syndrome and several individual components of the syndrome, including insulin resistance (35,36).”
Background
Effect of Fasting with Two Meals on BMI and Inflammatory Markers of Metabolic Syndrome
Shariatpan, M. V., Shariatpanahi, Z. V., Shahbazi, S., & Moshtaqi, M. (2012) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2012.255.258 · Cited by 19
The relationship of endothelial function and arterial stiffness with subclinical target organ damage in essential hypertension
Sun, Y., Liu, F., Zhang, Y., Lu, Y., Su, Z.-L., Ji, H., Cheng, Y., Song, W., Hidru, T. H., Yang, X., et al. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14447 · Cited by 19
The effects of exercise training on inflammatory markers in children and adolescents: A systematic review and meta-analysis
Khalafi, M., Symonds, M. E., Faramarzi, M., Sharifmoradi, K., Maleki, A. H., & Rosenkranz, S. K. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114524 · Cited by 20
The association between a low urine pH and the components of metabolic syndrome in the Korean population: Findings based on the 2010 Korea National health and nutrition examination survey.
Cho, Y. H., Lee, S. Y., Jeong, D. W., Choi, E. J., Nam, K.-J., Kim, Y. J., Lee, J. G., Yi, Y. H., Tak, Y. J., Cho, B. M., et al. (2014) · PubMed Central · Cited by 19
Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients
Badiou, S., Thiébaut, R., Aurillac-Lavignolle, V., Dabis, F., Laporte, F., Cristol, J., & Mercié, P. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.05.007 · Cited by 19
Does Gestational Diabetes History Increase Epicardial Fat and Carotid Intima Media Thickness?
Çalışkan, M., Çaklılı, Ö. T., Çalışkan, Z., Duran, C., Ciftci, F. C., Avcı, E., Güllü, H., Kulaksızoğlu, M., Koca, H., & Müderrisoğlu, H. (2014) · Echocardiography · doi:10.1111/echo.12597 · Cited by 21
Effects of Pioglitazone and Metformin Fixed‐Dose Combination Therapy on Cardiovascular Risk Markers of Inflammation and Lipid Profile Compared With Pioglitazone and Metformin Monotherapy in Patients With Type 2 Diabetes
Pérez, A., Jacks, R., Arora, V. K., & Spanheimer, R. G. (2010) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00389.x · Cited by 19
The Association of Metabolic Syndrome with Atrial Fibrillation: An Emerging Epidemiological and Pathophysiological Hypothesis
Korantzopoulos, P. G., Kokkoris, S., & Papaioannides, D. (2005) · Cardiology · doi:10.1159/000087636 · Cited by 19
Atherosclerosis risk factors in children of parents with the metabolic syndrome
Akıncı, G., Coşkun, Ş., Akıncı, B., Hekimsoy, Z., Bayındır, P., Onur, E., & Özmen, B. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.12.008 · Cited by 19
Chrononutrition in the context of Ramadan: Potential implications
Ali, T., & Lessan, N. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3728 · Cited by 18
Obesity, dyslipidemia, and high blood pressure are associated with cardiovascular risk, determined using high-sensitivity C-reactive protein concentration, in young adults
Ramos-Arellano, L. E., Matia‐García, I., Marino‐Ortega, L. A., Castro-Alarcón, N., Muñóz-Valle, J. F., Salgado-Goytia, L., Salgado-Bernabé, A. B., & Parra‐Rojas, I. (2020) · Journal of International Medical Research · doi:10.1177/0300060520980596 · Cited by 18
“Finally, in the Framingham Offspring Study, a significant relationship was identified between components of the metabolic syndrome or insulin resistance and high hs-CRP.(24) The low-grade systemic inflammation that is a feature of metabolic syndrome can be explained by the production of proinflammatory cytokines, such…”
Method
Inflammation, Reproduction, and the Goldilocks Principle
Clancy, K. B. H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4060-4_1 · Cited by 17
Razão triglicérides/HDL-C e proteína C reativa de alta sensibilidade na avaliação do risco cardiovascular
Vieira, E. A., Carvalho, W. A., Aras, R., Couto, F. D., & Couto, R. D. (2011) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442011000200004 · Cited by 18
An association of serum ALT with elevated blood pressure in senior adults: a case-control study
Hong, X., Wongtongkam, N., Ward, P., Xiao, S., Wang, S., Peng, Q., Zuo, Q., Zeng, D., Wang, J., Wang, C., et al. (2016) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2016.1200608 · Cited by 19
Soluble fibre as a treatment for inflammation in asthma
Williams, L. M., Scott, H. A., & Wood, L. G. (2019) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2019.100108 · Cited by 18
Metabolic syndrome and its components as predictors of stroke in middle-aged and elderly Chinese people
Jia, Z., Wu, S., Zhou, Y., Wang, W., Liu, X., Wang, L., Wang, Y., Wang, Y., Liang, W., Zhao, X., et al. (2011) · Neurological Research · doi:10.1179/016164111x13007856083882 · Cited by 18
Reduction of monocyte chemoattractant protein 1 and macrophage migration inhibitory factor by a polyphenol-rich extract in subjects with clustered cardiometabolic risk factors
Broekhuizen, L. N., van Wijk, D. F., Vink, H., Stalmach, A., Crozier, A., Hutten, B. A., Kastelein, J. J. P., Hugenholtz, P. G., Köenig, W., & Stroes, E. S. G. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511002431 · Cited by 18
A randomized clinical trial comparing metabolic parameters after 48 weeks of standard‐ and low‐dose stavudine therapy and tenofovir disoproxil fumarate therapy in HIV ‐infected S outh A frican patients
Menezes, C. N., Crowther, N. J., Duarte, R., Amsterdam, D. V., Evans, D. H., Dickens, C., Dix‐Peek, T., Rassool, M. S., Prinsloo, A. S., Raal, F. J., et al. (2013) · HIV Medicine · doi:10.1111/hiv.12074 · Cited by 17
Metabolic syndrome-related composite factors over 5years in the STANISLAS Family Study: Genetic heritability and common environmental influences
Herbeth, B., Samara, A., Ndiaye, C., Marteau, J., Berrahmoune, H., Siest, G., & Visvikis‐Siest, S. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.02.070 · Cited by 17
Effects of peripheral neuropathy on exercise capacity and quality of life in patients with chronic obstructive pulmonary diseases
Ulubay, G., Ulaşlı, S. S., Bozbaş, Ş. S., Özdemirel, T. Ş., & Karataş, M. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.28557 · Cited by 16
“Arch Med Sci 2, April / 2012 301 to be elevated in stable patients with COPD in several studies [5, 15, 17, 37-39].”
Background
Brief review and critical examination of the use of hs-CRP for cardiac risk assessment with the conclusion that it is premature to use this test
Levinson, S. S. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.12.021 · Cited by 16
Metabolic syndrome and risk for Type 2 diabetes
Meigs, J. B. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.1.57 · Cited by 17
Self-citation
C-reactive protein and the metabolic syndrome correlate differently with carotid atherosclerosis between men and women in a Taiwanese community
Chen, P., Chien, K., Hsu, H., Su, T., Chang, C., Sung, F., & Lee, Y. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.023 · Cited by 17
“In the Framingham population, Rutter et al [20] found that the association between the number of MetS components present and mean CRP levels was stronger in women than in men.”
Background
Relationship of C-reactive protein, metabolic syndrome and diabetes mellitus: potential role of statins.
Nash, D. T. (2005) · PubMed Central · Cited by 17
Dietary Patterns, Exercise, and the Metabolic Syndrome Among Young People in Urban Pakistan (Lahore)
Malik, M. S., Qayyum, W., Farooq, A., Waqas, A., Sukhera, A. B., Khalid, M. A., & Baig, A. A. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0021 · Cited by 16
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome
Cioffi, G., Viapiana, O., Tarantini, L., Orsolini, G., Idolazzi, L., Ognibeni, F., Dalbeni, A., Gatti, D., Fassio, A., Rossini, M., et al. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02520-y · Cited by 16
Utility of Serum Albumin for Predicting Incident Metabolic Syndrome According to Hyperuricemia
Lee, Y., Jun, J. E., Lee, S.-E., Ahn, J., Kim, G., Jee, J. H., Bae, J. C., Jin, S., & Kim, J. H. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0012 · Cited by 16
New circulating biomarkers for predicting cardiovascular death in healthy population
Melander, O., Modrego, J., Zamorano‐León, J. J., Santos-Sancho, J. M., Lahera, V., & López-Farré, A. J. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12652 · Cited by 16
Metabolic syndrome and C-reactive protein in stroke prediction: a prospective study in Taiwan
Chen, P., Chien, K., Hsu, H., Su, T., Sung, F., & Lee, Y. (2009) · Metabolism · doi:10.1016/j.metabol.2009.01.006 · Cited by 16
“The other study found that using both MetS and CRP does not increase the ability to discriminate cardiovascular events rather than using either one alone [12].”
BackgroundInfluential
Association of Inflammatory Biomarkers with Metabolic Syndrome in Hemodialysis Patients
Shahrokh, S., Heydarian, P., Ahmadi, F., Saddadi, F., & Razeghi, E. (2012) · Renal Failure · doi:10.3109/0886022x.2012.713280 · Cited by 16
Risk indicators of metabolic syndrome in young adults: A preliminary investigation on the influence of tobacco smoke exposure and gender
Corwin, E. J., McCoy, C. S., Whetzel, C. A., Ceballos, R. M., & Klein, L. C. (2006) · Heart & Lung · doi:10.1016/j.hrtlng.2005.09.003 · Cited by 16
Intravascular Kinetics of C-Reactive Protein and Their Relationships with Features of the Metabolic Syndrome
Mauger, J., Levesque, J., Paradis, M., Bergeron, N., Tchernof, A., Couture, P., & Lamarche, B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2585 · Cited by 16
Quantifying Cardiometabolic Risk Using Modifiable Non–Self-Reported Risk Factors
Marino, M., Li, Y., Pencina, M. J., D’Agostino, R. B., Berkman, L. F., & Buxton, O. M. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.03.006 · Cited by 15
Self-citation
Women's Health and the Metabolic Syndrome
Mitrakou, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.003 · Cited by 15
The importance of treating multiple cardiometabolic risk factors in patients with Type 2 diabetes
Mikhailidis, D. P., & Press, M. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.17.3009 · Cited by 15

Authors: Rutter, M. K., Meigs, J. B., Sullivan, L. M., D’Agostino, R. B., & Wilson, P. W. F.
Affiliations: Boston University (US)
ORCID: Rutter, Martin K.
Meigs, James B.
Sullivan, Lisa M.
D’Agostino, Ralph B.
Wilson, Peter W.F.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-07-27
Volume: 110
Issue: 4
Pages: 380-385
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000136581.59584.0e
OpenAlex: W1983997573
Cited by: 664
References: 36
Citations by year: 2026: 4 · 2025: 7 · 2024: 9 · 2023: 15 · 2022: 19 · 2021: 9 · 2020: 8 · 2019: 11 · 2018: 15 · 2017: 13 · 2016: 19 · 2015: 20 · 2014: 36 · 2013: 36 · 2012: 26
FWCI: 48.38
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (submittedVersion)
Funders: National Institutes of Health (n01hc25195-41-0-1)
National Heart, Lung, and Blood Institute (R01HL073272, N01‐HC25195, R01-HL 073272-01)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: C-reactive protein, metabolic syndrome, cardiovascular risk prediction, inflammation, insulin resistance, sex differences, Framingham Offspring Study, cardiovascular events, risk discrimination, cardiovascular risk in women, NCEP ATP III criteria, Framingham risk score, Framingham risk equation
MeSH terms: Adult, Aged, Aged, 80 and over, C-Reactive Protein, Cardiovascular Diseases, Cross-Sectional Studies, Female, Follow-Up Studies, Humans, Inflammation, Insulin Resistance, Male, Middle Aged, Predictive Value of Tests, Risk, Sex Factors, Cohort Studies, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks